ID   SRH
AC   CVCL_A0XB
DR   cancercelllines; CVCL_A0XB
DR   Wikidata; Q108821326
RX   PubMed=33322555;
CC   Doubling time: 34.3 +- 2.5 hours (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; Simple; p.Leu122Arg (c.365T>G); Zygosity=Homozygous (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Unspecified (PubMed=33322555).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Left leg, skeletal muscle; UBERON=UBERON_0001383.
ST   Source(s): PubMed=33322555
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,31.2
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C121654; Spindle cell/sclerosing rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=33322555; DOI=10.3390/cells9122668; PMCID=PMC7763666;
RA   Schleicher S., Grote S., Malenke E., Chan K.C.-H., Schaller M.,
RA   Fehrenbacher B., Riester R., Kluba T., Frauenfeld L., Boesmueller H.,
RA   Gohring G., Schlegelberger B., Handgretinger R., Kopp H.-G., Traub F.,
RA   Boehme K.A.;
RT   "Establishment and characterization of a sclerosing spindle cell
RT   rhabdomyosarcoma cell line with a complex genomic profile.";
RL   Cells 9:2668.1-2668.26(2020).
//